Evidence map›Paper›PMID 36266398›Full record

ArticleScientific reports2022

Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis.

Jiří Hrdý, Aurélie Couturier-Maillard, Denise Boutillier, Carmen Lapadatescu, Philippe Blanc, Jan Procházka, Bruno Pot, Bernhard Ryffel, Corinne Grangette, Mathias Chamaillard

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Maternal curcumin supplementation alleviates intestinal inflammation ofAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Group 3 innate lymphoid cells in intestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  13. Probiotics: Shaping the gut immunological responses.World journal of gastroenterology · 2024
    Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiří HrdýUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France.
Aurélie Couturier-MaillardINEM-UMR7355, Molecular Immunology, Institute of Infectious Diseases and Molecular Medicine (IDM), and Infectious Diseases, University and CNRS, Orléans, France.
Denise BoutillierUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France.
Carmen LapadatescuBioprox, 7 rue Aristide Briand, 92300, Levallois-Perret, France.
Philippe BlancBioprox, 7 rue Aristide Briand, 92300, Levallois-Perret, France.
Jan ProcházkaInstitute of Molecular Genetics, Czech Centre for Phenogenomics, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.
Bruno PotUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France.
Bernhard RyffelINEM-UMR7355, Molecular Immunology, Institute of Infectious Diseases and Molecular Medicine (IDM), and Infectious Diseases, University and CNRS, Orléans, France.
Corinne GrangetteUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France. corinne.grangette@pasteur-lille.fr.
Mathias ChamaillardUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France. mathias.chamaillard@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Live biotherapeutic products constitute an emerging therapeutic approach to prevent or treat inflammatory bowel diseases. Lactobacillus acidophilus is a constituent of the human microbiota with probiotic potential, that is illustrated by improvement of intestinal inflammation and antimicrobial activity against several pathogens. In this study, we evaluated the immunomodulatory properties of the L. acidophilus strain BIO5768 at steady state and upon acute inflammation. Supplementation of naïve mice with BIO5768 heightened the transcript level of some IL-17 target genes encoding for protein with microbicidal activity independently of NOD2 signaling. Of these, the BIO5768-induced expression of Angiogenin-4 was blunted in monocolonized mice that are deficient for the receptor of IL-17 (but not for NOD2). Interestingly, priming of bone marrow derived dendritic cells by BIO5768 enhanced their ability to support the secretion of IL-17 by CD4

Indexed as

ColitisImmunity, InnateInflammatory Bowel DiseasesLactobacillus acidophilusProbioticsAnimalsBifidobacterium animalisEnterobacteriaceae InfectionsInflammationInterleukin-17LymphocytesMiceTrinitrobenzenesulfonic AcidInterleukin-17Trinitrobenzenesulfonic Acid

Identifiers

PMID36266398
PMCPMC9585059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.